Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

436 public trials 71 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.

NCT03422068

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Odense University Hospital Odense, Denmark
  • HYKS Keuhkosairauksien tutkimusyksikkö Helsinki, Finland
  • TYKS Turku, Finland
  • Fraunhofer ITEM Hanover, Germany
View Trial Details
Completed

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

NCT05185089

Conditions
Cough, Idiopathic Pulmonary Fibrosis, Lung Diseases, +7 more
Locations
  • University of Southern California Los Angeles, California, United States
  • University of California San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Loyola University Chicago Maywood, Illinois, United States
View all 37 locations
View Trial Details
Completed

Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

NCT06331624

Conditions
IPF, Idiopathic Pulmonary Fibrosis, Lung Diseases, +3 more
Locations
  • Newport Native MD, Inc. Newport Beach, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Southeastern Research Center Winston-Salem, North Carolina, United States
View all 16 locations
View Trial Details
Completed

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321069

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 334 locations
View Trial Details
Completed

Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

NCT05671835

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • The Kirklin Clinic of University of Alabama Birmingham Hospital Birmingham, Alabama, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine (UCI) Health Orange, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

NCT04614441

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Chang-Hua Christian Hospital Changhua, Taiwan
  • Chang Gung Memorial Hospital Chiayi Chiayi City, Taiwan
  • National Taiwan University Hospital-Hsin-Chu Branch Hsinchu, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
View all 26 locations
View Trial Details

Related conditions